Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (301-310 of 548) with videos related to

Pageof 55
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus)E C Maratos, M J Jackson, R K Pearce, et al.
The Journal of Pharmacy and Pharmacology|June 1, 1980
Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparationsA E Theodorou, M D Hall, P Jenner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 21, 2013
Cholinergic manipulation of motor disability and L-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosetsM J Jackson, T Swart, R K B Pearce, et al.
Experimental Brain Research|January 1, 1986
Effects of somatostatin on dopamine sensitive adenylate cyclase activity in the caudate-putamen of the ratA Moser, C Reavill, P Jenner, et al.
Neuroscience|March 8, 2002
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegenerationM M Iravani, K Kashefi, P Mander, et al.
Neuroscience|July 1, 1994
Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patientsA Fernandez, M L de Ceballos, P Jenner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 22, 2002
The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administrationL A Smith, M J Jackson, G Al-Barghouthy, et al.
Life Sciences|August 14, 1978
A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugsP Jenner, A Clow, C Reavill, et al.
Brain Research|October 25, 1991
Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult ratsY Takeuchi, T Sawada, S Blunt, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodiesA D Owen, A H Schapira, P Jenner, et al.
Pageof 55

Showing results (301-310 of 548) with videos related to

Sort By:
Pageof 55
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus)E C Maratos, M J Jackson, R K Pearce, et al.
The Journal of Pharmacy and Pharmacology|June 1, 1980
Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparationsA E Theodorou, M D Hall, P Jenner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 21, 2013
Cholinergic manipulation of motor disability and L-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosetsM J Jackson, T Swart, R K B Pearce, et al.
Experimental Brain Research|January 1, 1986
Effects of somatostatin on dopamine sensitive adenylate cyclase activity in the caudate-putamen of the ratA Moser, C Reavill, P Jenner, et al.
Neuroscience|March 8, 2002
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegenerationM M Iravani, K Kashefi, P Mander, et al.
Neuroscience|July 1, 1994
Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patientsA Fernandez, M L de Ceballos, P Jenner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 22, 2002
The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administrationL A Smith, M J Jackson, G Al-Barghouthy, et al.
Life Sciences|August 14, 1978
A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugsP Jenner, A Clow, C Reavill, et al.
Brain Research|October 25, 1991
Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult ratsY Takeuchi, T Sawada, S Blunt, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodiesA D Owen, A H Schapira, P Jenner, et al.
Pageof 55